Science Pool

International Conference on Antiviral Research (ICAR) 2022

Posted by Evotec on Feb 8, 2022 2:21:43 PM

Date: 21 - 25 March 2022

Location: Renaissance Seattle Hotel, Seattle, WA, United States | Hybrid Event

Attending: Kara Carter, Antoine Alam, Jon Gunther, Randal Ketchem, and Cristina Loomis

 

Evotec will be sponsoring ICAR 2022 and showcasing its research along with our Just - Evotec Biologics colleagues. 

 

Presentation

AI-Derived Antibody Discovery - Humanoids for Global Good

Randal Ketchem, SVP Biotherapeutic Discovery and Molecular Design at Just – Evotec Biologics
Thursday, March 24 | 2:45 pm - 5:45 pm

 

Presentation

A Bifunctional Immune Modulator Exhibits Potent Antiviral Activity in HBV Infection Models

Antoine Alam, Head of Virology at Evotec
Friday, March 23 | 12:15 pm - 1:00 pm

 

Poster

AI-Derived Antibodies Are Novel, Diverse and Pharmacologically Active Against Multiple Sars-Cov-2 Strains

Cristina Loomis, Principle Scientist, Antibody Discovery at Just-Evotec Biologics

 

Kara Carter will be chairing four sessions:

Monday, March 21 | 4:30 pm - 5:30 pm
Gertrude Elion Memorial Award Lecture

Tuesday, March 22 | 2:00 pm - 2:45 pm
William Prusoff Memorial Award Lecture

Wednesday, March 23 |  8:30 am - 9:15 am
Antonín Holý Memorial Award Lecture

Thursday, March 24 | 2:45 pm - 5:45 pm
Coronaviruses



If you wish to meet with us in Seattle, get in touch via the form below, we will be happy to arrange a meeting.

Tags: Events, Evotec, Just Evotec Biologics

8th RSC/SCI Symposium on GPCRs in Medicinal Chemistry

Posted by Evotec on Jan 28, 2022 10:03:54 AM

Date: 5th - 7th October 2022

Location: Hosted at the Evotec Campus Levi-Montalcini in Verona, Italy

Evotec will host the 8th meeting in the series on GPCR drug discovery at its site in Verona, Italy. We are really happy to host this symposium again in Verona after the last in-person event held in 2018.

The symposium is organised by: RSC Biological and Medicinal Chemistry Sector and SCI Fine Chemicals Group

Evotec will contribute to the scientific program with two presentations: 

The resolution revolution: GPCR structure-based drug design in 20:20 vision (in 2022)
Speaker: James Errey, Evotec, UK

GPCR-based drug design with fragment molecular orbital method
Speaker: Alexander Heifetz, Evotec, UK

Please note poster abstract submission deadline is August 11th, 2022 - Submit your abstract!

Looking forward to meeting all the delegates in Verona in October!

Learn more about the symposium and download the announcement here

Tags: Events, Evotec

AACR Annual Meeting 2022

Posted by Evotec on Jan 26, 2022 4:47:59 PM

Date: 8th - 13th April 2022

Location: New Orleans Ernest N. Morial Convention Center, LA, United States

Attending: Francisco Cruzalegui, Michael Esquerre, Pierre Fons, Pascale Lejeune, Itta MacNevin, Jeremiah Treanor, Nathalie Joly

 

Find out about the science Evotec will show here

Join our scientific experts at booth #1111!

 

If you wish to meet with us in New Orleans, get in touch via the form below, we will be happy to arrange a meeting.

Learn more about AACR 

Tags: Events, Evotec

61st SOT Annual Meeting and ToxExpo 2022

Posted by Evotec on Jan 26, 2022 11:06:29 AM

Date: 27th - 31st March 2022

Location: San Diego Convention Center, CA, United States

Attending: Christopher Strock, Claire White, David Cerny, Felix von Haniel, Illaria Masotto, Matteo Sartori, Michael Campognone, Monday Ogese, Paul Walker, Ralf Geiben Lynn, Stephen Madden

Cyprotex and Evotec will be exhibiting and showcasing their research at the 61st Annual Society of Toxicology Meeting (SOT) and ToxExpo on March 27-31 in San Diego, CA.

Join our scientific specialists at booth #1226-1127 and don't forget to include our hosted seminar and poster presentations in your SOT itinerary!

If you wish to meet with us in San Diego, get in touch via the form below, we will be happy to arrange a meeting.

Our scientific program

Cyprotex Hosted Seminar
Multi-Organ and Species-Specific Safety Profiling using Transcriptomics
Presented by Paul Walker, PhD
Date: March 29, 2022
Time: 10:30 AM - 11:30 AM PDT
Room: 23C

Poster Presentations
Identifying Seizures with MEA: Complementary Human and Rat Neuronal Models Enhance Predictivity
Presented by Chris Strock, PhD
Date: March 28, 2022
Time: 2:30 PM- 4:15 PM PDT
Abstract Number/Poster number: 3289/P439

Development of In Vitro Assays to Predict Potential Immunotoxicological Liabilities of Candidate Drugs using Human Peripheral Blood Mononuclear Cells
Presented by Monday Ogese, PhD
Date: March 29, 2022
Time: 9 AM- 10:45 AM PDT
Abstract Number/Poster number: 4121/P825

Evaluating Functional and Structural Cardiotoxicants using Calcium Flux, HCI and High Throughput Transcriptomics
Presented by Stephen Madden, PhD
Date: March 30, 2022
Time: 9 AM - 10:45 AM PDT
Abstract Number/Poster number: 4377/P331

High Throughput RNA-Seq Profiling of 3D Liver Organoids to Predict Drug-Induced Liver Injury (DILI)
Presented by Paul Walker, PhD
Date: March 30, 2022
Time: 10:45 AM- 12:30 PM PDT
Abstract Number/Poster number: 4449/P449

Learn more about the 61st SOT Annual Meeting and ToxExpo

Tags: Events, Evotec, Cyprotex

Gordon Research Conference - New Antibacterial Discovery and Development

Posted by Evotec on Nov 18, 2021 10:13:25 AM

Date: July 24th-29th, 2022

Venue: Renaissance Tuscany Il Ciocco, Lucca | Barga, Italy

Attendees: Alastair Parkes, Stephane Vandenbeele, Guiseppe D'Angelo, Florian Marro

 

Evotec will be sponsoring the New Antibacterial Discovery and Development Conference, as well as showcasing its research on-site in Italy.

 

Our scientific program

 

Presentation

Using Probabilistic Approaches and AI/ML to advance antibacterial drug discovery projects

Alastair Parkes, VP Head of Department III, Medicinal Chemistry

Wednesday, 27 July | 11.30 am - 11.50am

 

Poster Presentation

Intracellular Staphylococcus aureus replicative dynamics monitoring under antibiotics challenges: highlighting persisters.

Florian C. Marro, Research Associate, Mass Spectrometry & Phenomics

Poster Sessions are scheduled 4:30 pm - 6:00 pm from 25-28 July 2022.

 

If you wish to meet with us in Italy, get in touch via the form below, we will be happy to arrange a meeting.

 

Learn more about the GRC - New Antibacterial Discovery and Development.

Tags: Events, Evotec

Join our Innovation Week

Posted by Evotec on Nov 11, 2021 4:51:59 PM

Take a Ride on the Evotec "Data-Driven R&D Autobahn to Cures"

5 Virtual Sessions over 5 Days

Date: 6 - 10 November 2021 Online | 9 - 11 November 2021 Fiera Milano

Location: Virtual

  • Learn how Evotec is using data and science across treatment modalities to accelerate innovation in the area of precision medicine to deliver enhanced speed, lower cost, and predictive efficacy

  • Find out about our efforts in AI/ML in the design and development of both small molecules and antibodies, the importance of  biomarker development, targeting RNA, and our approaches to target validation

 

Day 1:
Drug Discovery in Evotec Multiverse: Knowledge-driven Integrated R&D

Presented by: Adam Davenport, Tim James and Christophe Boldron
When | Monday 6 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET


Day 2:
The Importance of Precision Medicine: How Biomarkers Optimise Translation from Bench to Bedside and Back

Presented by: Elizabeth van der Kam, Christoph Schaab
When |Tuesday 7 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET


Day 3:
The Early Bird Catches the Helix: Expanding the Druggable Target Space to RNA

Presented by: Steffen Grimm, Hilary Brooks
When | Wednesday 8 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET


Day 4:
Do Firefighters cause Fires? Establishing Real Disease Associations through Target Validation

Presented by: Hauke Cornils, Susan Boyce
When |Thursday 9 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET


Day 5:
Translate your Idea into Product: AI-Driven Antibody Discovery at Evotec

Presented by: Barbara Bachler-Konetzki, Randal Ketchem, Maria Pilla
When | Friday 10 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET


Each session will take approx. 45 min including Q&A. You will need to register for each day separately to reserve your seat.

RESERVE YOUR SEAT

Tags: Events, Evotec, Just Evotec Biologics

Emerging Antimicrobials and Diagnostics in AMR (EADA) 2021

Posted by Evotec on Nov 11, 2021 10:41:19 AM

Date: 18th November 2021

Venue: Virtual

Attendee: Dr Alastair Parkes, Group Leader at Evotec will be presenting on "Novel LpxA inhibitors targeting Pseudomonas aeruginosa"

Learn More About the EADA Conference

Tags: Events, Evotec

Immunotherapies & Innovations for Infectious Diseases 2021- I4ID

Posted by Evotec on Nov 10, 2021 5:34:06 PM

Date: 15th-16th November 2021

Location: ENS Campus Gerland, Lyon, France

Attendee: Antoine Alam, VP Virology will be presenting on "CD40 agonists boost IFN-induced signaling pathway and subsequent anti-HBV response in vitro and in vivo"

Huge Watson, Virology Clinical Development will be presenting a poster entitled "Household clustering suggests a novel chemoprophylaxis trial design for an arboviral disease"

Francesca Bernardini, VP In Vitro Biology, Sébastien Coyne, Group Leader In Vitro Biology, Kara Carter, Virology Entrepreneur in Residence, Lilia Boucinha, Team Leader, Bioinformatics

Learn More About I4ID

Tags: Events, Evotec

Discovery UK 2021

Posted by Evotec on Oct 19, 2021 1:40:10 PM


Date: 26th -27th October 2021

Location: London, UK 

Evotec is a sponsor of Discovery UK 2021 (organised by Oxford Global)

Our Senior Vice President, Global Head of Protein Sciences, John Barker will present on "Discovery of Novel UDP-N-Acetylglucosamine Acyltransferase (LpxA) Inhibitors With Activity Against Pseudomonas aeruginosa" on October 27th at 9:50am in the Molecular Drug Design & Medicinal Chemistry, & The Optimisation of HITS stream

Our delegates: Jason Brown, Oksana Nikolayenko, John Barker

Learn more about Discovery UK 2021

Tags: Events, Evotec

Convergence Forum 2021

Posted by Evotec on Oct 19, 2021 1:14:28 PM


Date: 28th -29th October 2021

Location: Wequassett Resort & Golf Club in Chatham, MA on Cape Cod, US

Evotec is a sponsor of Convergence Forum 2021

Our Global Head, Integrated Drug Discovery, Karen Lackey will be speaking at the mainstage session on Thursday, October 28th 11:45 AM - 12:30 PM on “Today's Applications of AI in Drug Discovery — and What Comes Next” with Kristen Fortney, PhD, CEO and co-founder at BioAge - Moderator: Rich Kivel, Managing Director, GrayBella Capital

Attendees: Ryan Brady, Itta MacNevin, Karen Lackey

Learn more about Convergence Forum 2021

Tags: Events, Evotec